Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scripts

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Therapeutics, brings scientific expertise and deal-making skills. She is poised to lead Biocon into its next growth phase. The company is focusing on biosimilars and advanced biologics.